Elevance Health (ELV) Payables (2009 - 2026)

Elevance Health (ELV) has 18 years of Payables data on file, last reported at $6.6 billion in Q2 2026.

• On a quarterly basis, Payables fell 13.17% year-over-year to $6.6 billion in Q2 2026; TTM through Jun 2026 was $6.6 billion, a 13.17% decrease from a year earlier, with the FY2025 full-year figure at $7.5 billion, up 2.47% from the prior year.
• Payables for Q2 2026 stood at $6.6 billion, down from $6.9 billion in the prior quarter.
• Over the last five years, Payables for ELV reached as high as $7.6 billion in Q2 2025 and fell as low as $5.1 billion in Q1 2023.
• Historically, Payables has averaged $6.4 billion across 5 years, with a median of $6.4 billion in 2024.
• Across the five-year window, Payables retreated 14.78% in 2022 and soared 40.77% in 2024, its largest moves.
• Year by year, Payables stood at $5.9 billion in 2022, then rose by 21.51% to $7.1 billion in 2023, then advanced by 2.2% to $7.3 billion in 2024, then grew by 2.47% to $7.5 billion in 2025, then decreased by 11.24% to $6.6 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $6.6 billion in Q2 2026, $6.9 billion in Q1 2026, and $7.5 billion in Q4 2025.